Cipla net profit jumps 78.7% to Rs 931.87 cr in Q4
New Delhi: Pharma major Cipla Ltd Friday reported a 78.7 per cent jump in consolidated net profit to Rs 931.87 ...
Read more
New Delhi: Pharma major Cipla Ltd Friday reported a 78.7 per cent jump in consolidated net profit to Rs 931.87 ...
Read moreNew Delhi: Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues. In ...
Read moreNew Delhi: Cipla shares were down by more than 7 per cent Thursday after the US FDA issued a warning ...
Read moreNew Delhi: The Indian equity indices -- S&P BSE Sensex and NSE Nifty50 -- settled higher Friday, the last trading ...
Read moreNew Delhi: India’s drug regulator Drugs Controller General of India (DCGI) has granted permission to Cipla to import Moderna's Covid-19 ...
Read moreNew Delhi: Cipla Limited announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen for Covid-19 in India, ...
Read moreNew Delhi: Pharma major Cipla said Wednesday it has launched its generic version of anti-viral drug remdesivir at a price ...
Read moreNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read more
I t may appear strange in most democracies, including India, that losing a no-confidence vote against a government leading to...
Read more
The collapse of Bashar al-Assad’s regime in Syria is not an isolated event in the Middle East, but part of...
Read more
The people of South Korea and their representatives showed the world last weekend how real democracy works. The country’s parliament...
Read more
In 2021, I wrote a book called “Price of the Modi Years.” In one of its chapters, I compared India’s...
Read more
